Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DiaMedica Therapeutics Inc
DMAC | US
4.29
USD-0.05
-1.15%
DMAC | US
About DiaMedica Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
4.29
Open
4.29
High
4.30
Low
4.23
DiaMedica Therapeutics Inc. a clinical stage biopharmaceutical company develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199 a recombinant human tissue kallikrein-1 protein which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke. It is also developing DM300 that is in pre-clinical stage for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc. and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis Minnesota.
View LessDMAC | US
Risk
48.0
Sharpe
1.33
Luna's Score
52/100
Recommendation
Hold
Luna says (DMAC | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
51.2%1 month
48.0%3 months
53.9%6 months
77.3%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
3.43
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
-0.96
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-22.35M
MarketCap
183.39M
MarketCap(USD)
183.39M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-35.18
Short ratio
2.37
Short perc.
0.52
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.59
Range1M
0.91
Range3M
1.70
Volumes: Market Activity
Rel. volume
0.25
Price X volume
55.53K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.96 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 3.43 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 53.92 | - | Lower Risk |
| Debt to Equity | 0.01 | -1.23 | Expensive |
| Debt to Assets | 0.01 | 0.25 | Cheaper |
| Market Cap | 183.39M | - | Emerging |
